Need Help?
Order Article Reprints
Journal: Med. Sci. Forum, 2025
Volume: 39
Number: 2
2
Article:
First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer
Authors:
by
Simon Nannini, Fabien Moinard-Butot, Sylvain Ladoire, Dorian Bochaton, Pierre Bigot, Félix Lefort, Hakim Mahammedi, Fabien Calcagno, Jean-Baptiste Barbe Richaud, Luca Campedel, Sabrina Falkowski, Karim Amrane, Haris Charalambous, Pierre Cornillon and Philippe Barthélémy
Link:
https://www.mdpi.com/2673-9992/39/1/2
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Nannini, S.; Moinard-Butot, F.; Ladoire, S.; Bochaton, D.; Bigot, P.; Lefort, F.; Mahammedi, H.; Calcagno, F.; Richaud, J.-B.B.; Campedel, L.; et al. First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer. Med. Sci. Forum 2025, 39, 2. https://doi.org/10.3390/msf2025039002
Nannini S, Moinard-Butot F, Ladoire S, Bochaton D, Bigot P, Lefort F, Mahammedi H, Calcagno F, Richaud J-BB, Campedel L, et al. First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer. Medical Sciences Forum. 2025; 39(1):2. https://doi.org/10.3390/msf2025039002
Chicago/Turabian StyleNannini, Simon, Fabien Moinard-Butot, Sylvain Ladoire, Dorian Bochaton, Pierre Bigot, Félix Lefort, Hakim Mahammedi, Fabien Calcagno, Jean-Baptiste Barbe Richaud, Luca Campedel, and et al. 2025. "First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer" Medical Sciences Forum 39, no. 1: 2. https://doi.org/10.3390/msf2025039002
APA StyleNannini, S., Moinard-Butot, F., Ladoire, S., Bochaton, D., Bigot, P., Lefort, F., Mahammedi, H., Calcagno, F., Richaud, J.-B. B., Campedel, L., Falkowski, S., Amrane, K., Charalambous, H., Cornillon, P., & Barthélémy, P. (2025). First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer. Medical Sciences Forum, 39(1), 2. https://doi.org/10.3390/msf2025039002
